CMPI · Categories · Form 4

CMPI - SEC Form 4 insider transactions

Checkmate Pharmaceuticals Inc. (CMPI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CMPI

• 1469d
  SEC Form 4 filed by Powell Michael

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1469d
  SEC Form 4 filed by Flaherty Keith T.

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1469d
  SEC Form 4 filed by Isacoff Oren

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1469d
  SEC Form 4 filed by Colabuono Peter

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1469d
  SEC Form 4 filed by Yan Joy

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1469d
  SEC Form 4 filed by Dolski Robert

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1469d
  SEC Form 4 filed by Wooldridge James

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1469d
  SEC Form 4 filed by Wigginton Jon Marc

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1469d
  SEC Form 4 filed by Fuhrman Alan

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1469d
  SEC Form 4 filed by Bash Alan

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1482d
  SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $1,375,564 worth of shares (131,650 units at $10.45)

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1487d
  SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $1,671,824 worth of shares (160,901 units at $10.39)

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1490d
  SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $898,921 worth of shares (86,677 units at $10.37)

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1495d
  SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $2,809,332 worth of shares (270,675 units at $10.38)

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1500d
  SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $1,972,579 worth of shares (190,026 units at $10.38)

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1501d
  SEC Form 4 filed by Wooldridge James

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1503d
  SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $1,347,796 worth of shares (129,781 units at $10.39)

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1508d
  SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $5,700,491 worth of shares (547,734 units at $10.41)

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1558d
  SEC Form 4 filed by Bash Alan

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1587d
  SEC Form 4 filed by Wigginton Jon Marc

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1588d
  SEC Form 4 filed by Dolski Robert

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1588d
  SEC Form 4 filed by Wooldridge James

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1633d
  SEC Form 4 filed by Yan Joy

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1682d
  SEC Form 4 filed by Fuhrman Alan

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1762d
  SEC Form 4 filed by POWELL MICHAEL

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1766d
  SEC Form 4 filed by Wooldridge James

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1766d
  SEC Form 4 filed by Chaudhary Kleem

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1766d
  SEC Form 4 filed by Dolski Robert

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1766d
  SEC Form 4 filed by Labinger Barry

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1812d
  SEC Form 4 filed by Flaherty Keith T.

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1812d
  SEC Form 4 filed by Fuhrman Alan

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1812d
  SEC Form 4 filed by Isacoff Oren

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1812d
  SEC Form 4 filed by Colabuono Peter

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1812d
  SEC Form 4 filed by POWELL MICHAEL

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1812d
  SEC Form 4: Krieg Arthur M bought $43,633 worth of Common Stock (7,224 units at $6.04), increasing direct ownership by 0.89% to 815,734 units

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1816d
  SEC Form 4: Krieg Arthur M bought $22,112 worth of Common Stock (3,578 units at $6.18), increasing direct ownership by 0.44% to 808,510 units

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1832d
  SEC Form 4 filed by Krieg Arthur M

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1894d
  SEC Form 4: M Arthur Krieg bought $370,673 worth of Common Stock (33,220 units at $11.16), increasing direct ownership by 4% to 779,931 units

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1896d
  SEC Form 4: M Arthur Krieg bought $166,275 worth of Common Stock (13,520 units at $12.30), increasing direct ownership by 2% to 746,711 units

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1924d
  SEC Form 4: Kleem Chaudhary exercised 2,000 units of Common Stock at a strike of $2.62, increasing ownership by 33% to 8,000 units

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1956d
  SEC Form 4: M Arthur Krieg bought $22,198 worth of Common Stock (1,701 units at $13.05), increasing ownership by 0.23% to 733,191 units

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
• 1963d
  SEC Form 4: M Arthur Krieg bought $6,545 worth of Common Stock (500 units at $13.09), increasing ownership by 0.07% to 731,490 units

  4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)

Other CMPI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends